Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma with Extensive Central Nervous System Metastasis.

Kim, Tae Woo; Lee, Kyung Mi; Lee, Seung Hyeun

Kim, Tae Woo; Lee, Kyung Mi; Lee, Seung Hyeun.

Afiliación

Kim TW; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, South Korea.
Lee KM; Department of Radiology, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, South Korea.
Lee SH; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, South Korea.

Onco Targets Ther ; 15: 941-946, 2022.

Article en En | MEDLINE | ID: mdl-36072511

Palabras clave

MET exon 14 skipping mutation; capmatinib; leptomeningeal metastasis; lung cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google